These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 9384607)

  • 41. Functional categorization of gene expression changes in the cerebellum of a Cln3-knockout mouse model for Batten disease.
    Brooks AI; Chattopadhyay S; Mitchison HM; Nussbaum RL; Pearce DA
    Mol Genet Metab; 2003 Jan; 78(1):17-30. PubMed ID: 12559844
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures.
    Ding SL; Tecedor L; Stein CS; Davidson BL
    Neurobiol Dis; 2011 Feb; 41(2):237-48. PubMed ID: 20875858
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3).
    Aldrich A; Bosch ME; Fallet R; Odvody J; Burkovetskaya M; Rama Rao KV; Cooper JD; Drack AV; Kielian T
    Ann Neurol; 2016 Dec; 80(6):909-923. PubMed ID: 27804148
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Localization and processing of CLN3, the protein associated to Batten disease: where is it and what does it do?
    Pearce DA
    J Neurosci Res; 2000 Jan; 59(1):19-23. PubMed ID: 10658181
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of the batten disease protein CLN3 leads to mis-trafficking of M6PR and defective autophagic-lysosomal reformation.
    Calcagni' A; Staiano L; Zampelli N; Minopoli N; Herz NJ; Di Tullio G; Huynh T; Monfregola J; Esposito A; Cirillo C; Bajic A; Zahabiyon M; Curnock R; Polishchuk E; Parkitny L; Medina DL; Pastore N; Cullen PJ; Parenti G; De Matteis MA; Grumati P; Ballabio A
    Nat Commun; 2023 Jul; 14(1):3911. PubMed ID: 37400440
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intracellular trafficking of the JNCL protein CLN3.
    Haskell RE; Derksen TA; Davidson BL
    Mol Genet Metab; 1999 Apr; 66(4):253-60. PubMed ID: 10191111
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antigen presenting cell abnormalities in the Cln3(-/-) mouse model of juvenile neuronal ceroid lipofuscinosis.
    Hersrud SL; Kovács AD; Pearce DA
    Biochim Biophys Acta; 2016 Jul; 1862(7):1324-36. PubMed ID: 27101989
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Splicing variants in sheep CLN3, the gene underlying juvenile neuronal ceroid lipofuscinosis.
    Oswald MJ; Palmer DN; Damak S
    Mol Genet Metab; 1999 Jun; 67(2):169-75. PubMed ID: 10356317
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered sensitivity of cerebellar granule cells to glutamate receptor overactivation in the Cln3(Δex7/8)-knock-in mouse model of juvenile neuronal ceroid lipofuscinosis.
    Finn R; Kovács AD; Pearce DA
    Neurochem Int; 2011 May; 58(6):648-55. PubMed ID: 21315126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CLN3 protein regulates lysosomal pH and alters intracellular processing of Alzheimer's amyloid-beta protein precursor and cathepsin D in human cells.
    Golabek AA; Kida E; Walus M; Kaczmarski W; Michalewski M; Wisniewski KE
    Mol Genet Metab; 2000 Jul; 70(3):203-13. PubMed ID: 10924275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CLN3L, a novel protein related to the Batten disease protein, is overexpressed in Cln3-/- mice and in Batten disease.
    Narayan SB; Pastor JV; Mitchison HM; Bennett MJ
    Brain; 2004 Aug; 127(Pt 8):1748-54. PubMed ID: 15240430
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A disrupted homologue of the human CLN3 or juvenile neuronal ceroid lipofuscinosis gene in Saccharomyces cerevisiae: a model to study Batten disease.
    Guo WX; Mao C; Obeid LM; Boustany RM
    Cell Mol Neurobiol; 1999 Oct; 19(5):671-80. PubMed ID: 10384264
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Age-dependent alterations in neuronal activity in the hippocampus and visual cortex in a mouse model of Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
    Burkovetskaya M; Karpuk N; Kielian T
    Neurobiol Dis; 2017 Apr; 100():19-29. PubMed ID: 28042098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spectrum of mutations in the Batten disease gene, CLN3.
    Munroe PB; Mitchison HM; O'Rawe AM; Anderson JW; Boustany RM; Lerner TJ; Taschner PE; de Vos N; Breuning MH; Gardiner RM; Mole SE
    Am J Hum Genet; 1997 Aug; 61(2):310-6. PubMed ID: 9311735
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lack of specificity of antibodies raised against CLN3, the lysosomal/endosomal transmembrane protein mutated in juvenile Batten disease.
    Nelson T; Pearce DA; Kovács AD
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29089465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of the Batten disease gene CLN3 prevents exit from the TGN of the mannose 6-phosphate receptor.
    Metcalf DJ; Calvi AA; Seaman MNj; Mitchison HM; Cutler DF
    Traffic; 2008 Nov; 9(11):1905-14. PubMed ID: 18817525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Caenorhabditis elegans homologues of the CLN3 gene, mutated in juvenile neuronal ceroid lipofuscinosis.
    De Voer G; Jansen G; van Ommen GJ; Peters DJ; Taschner PE
    Eur J Paediatr Neurol; 2001; 5 Suppl A():115-20. PubMed ID: 11588981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Juvenile neuronal ceroid-lipofuscinosis (Batten disease): a brief review and update.
    Rakheja D; Narayan SB; Bennett MJ
    Curr Mol Med; 2007 Sep; 7(6):603-8. PubMed ID: 17896996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High resolution MRI reveals global changes in brains of Cln3 mutant mice.
    Greene ND; Lythgoe MF; Thomas DL; Nussbaum RL; Bernard DJ; Mitchison HM
    Eur J Paediatr Neurol; 2001; 5 Suppl A():103-7. PubMed ID: 11588978
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected].
    Mitchison HM; Bernard DJ; Greene ND; Cooper JD; Junaid MA; Pullarkat RK; de Vos N; Breuning MH; Owens JW; Mobley WC; Gardiner RM; Lake BD; Taschner PE; Nussbaum RL
    Neurobiol Dis; 1999 Oct; 6(5):321-34. PubMed ID: 10527801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.